GP Monitoring of Those on Antidepressants
By DUNCAN DOUBLE Tony Kendrick, who I have mentioned before (see eg. previous post) is the first author of a paper about antidepressant withdrawal in general practice. It found that
Mainstream Psychiatry Continues to Minimise Significance of Antidepressant Withdrawal
By DUNCAN DOUBLE Mainstream psychiatry has minimised the significance of antidepressant withdrawal, as I first pointed out in a BMJ letter in 1997. My complaint then was that the Defeat
CPN Symposium 2024: Psychosocial approaches to distress
UK Critical Psychiatry Network Symposium 2024 UK Critical Psychiatry Network Symposium Thursday 11th April 2024 Venue: University College London Chadwick Building, Gower Street, London WC1E 6BT Room: G08 Programme 09:00
On the Neuroplasticity Hypothesis of Antidepressant Action
By MARK HOROWITZ On the neuroplasticity hypothesis of antidepressant action – I worked in a neurogenesis laboratory for 4 years and completed my PhD partly on this topic (For SSRIs).
Busting Myths about Psychosis & Antipsychotics with Prof Joanna Moncrieff
In this talk, Prof Joanna Moncrieff (University College London) looks at the evidence behind some common myths relating to psychosis and ‘antipsychotic’ drugs: the idea that psychosis or ‘schizophrenia’ are
Transition from the Clinical to the Community Context
By PINO PINI, Psychiatrist in Italy and the United Kingdom, MHE board member. Reflections on occasion of two Hearing Voices events. In my professional experience I have witnessed various significant
Why I don’t like the idea that mental disorder is a disease
By Joanna Moncrieff. This blog was inspired by a talk I gave at the conference of the American Association for Philosophy and Psychiatry in May 2017. The title of this talk was: Many